Business Type | Supplier, Distributor |
Brand Name | Menveo |
Form | Liquid |
Usage | Human Use |
Click to view more |
Product Details
Indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals 2 months through 55 years of age.
Single dose in adults through 10 to 55 years of age.
Hi! Simply click below and type your query.
Our experts will reply you very soon.